Alzheimer’s disease in patients with obstructive sleep apnea syndrome
Ημερομηνία
2020Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Background: Obstructive sleep apnea syndrome (OSAS) is a disorder with high prevalence among adults and is an independent risk factor for various diseases, especially those affecting the central nervous system (CNS). Continuous positive airway pressure (CPAP) is usually the optimal choice of treatment for OSAS. Alzheimer’s disease (AD) is a neurodegenerative disease affecting a large proportion of the elderly population. The purpose of this study was to collect information concerning the two pathological entities and investigate the effectiveness of CPAP in the treatment of AD. Materials and Methods: In this review, Twenty articles were found concerning OSAS and AD, of which one article was about treatment with donepezil and seven articles considered treatment with CPAP. Results: Serious OSAS and short sleep duration are associated with a high risk of developing dementia. Respiratory distress during sleep is associated with developing mild cognitive impairment at younger ages. The cerebrovascular damage of AD patients is correlated with the severity of OSAS. Lower cerebrospinal fluid levels are associated with memory disturbances and oxygen saturation parameters in patients with OSAS-AD. Continuous use of CPAP is related to the delayed onset of cognitive impairment and is suggested as an effective method of protecting cognitive function, depression, sleep quality and architecture, and daytime sleepiness in AD patients with good compliance. Treatment of CPAP patients with OSAS-AD is suggested as an effective method of protecting cognitive function. Conclusion: Clinicians dealing with AD patients should consider CPAP treatment when OSAS coexists. © 2020 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Serum vitamin D levels in patients with obstructive sleep apnea syndrome and level changes after continuous positive airway pressure therapy
Siachpazidou D.I., Kotsiou O.S., Stavrou V., Pastaka C., Gogou E., Kechagia M., Varsamas C., Economou N.-T., Zouridis S., Patrikioy E., Seitanidis G., Pinaka M., Sistou A., Hatzoglou C., Gourgoulianis K.I. (2021)Purpose: Patients with obstructive sleep apnea syndrome (OSAS) have been found to exhibit lower serum vitamin D levels, even when the control groups are matched for confounding conditions. However, contradictory studies ... -
C-reactive protein as a potential biomarker of residual obstructive sleep apnea following adenotonsillectomy in children
Bhattacharjee R., Kheirandish-Gozal L., Kaditis A.G., Verhulst S.L., Gozal D. (2016)Study Objectives: Adenotonsillectomy (AT) is first-line treatment for pediatric obstructive sleep apnea (OSA), with most children having improvements in polysomnography (PSG). However, many children have residual OSA ... -
Long-Term Impact of COVID-19 Pandemic in Sleep Quality and Lifestyle in Young Adults
Barbouzas A.E., Malli F., Daniil Z., Gourgoulianis K. (2022)Due to the evolution of COVID-19,restrictive measures were implemented. The quarantine resulted in significant changes in the social, economic, and psychological status of the population; however, its long-term effects ...